ENSG vs. PACS, ACHC, HQY, ITCI, BPMC, JAZZ, EXEL, STVN, ASND, and RVMD
Should you be buying The Ensign Group stock or one of its competitors? The main competitors of The Ensign Group include PACS Group (PACS), Acadia Healthcare (ACHC), HealthEquity (HQY), Intra-Cellular Therapies (ITCI), Blueprint Medicines (BPMC), Jazz Pharmaceuticals (JAZZ), Exelixis (EXEL), Stevanato Group (STVN), Ascendis Pharma A/S (ASND), and Revolution Medicines (RVMD). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and The Ensign Group (NASDAQ:ENSG) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership.
The Ensign Group has a net margin of 5.67% compared to The Ensign Group's net margin of 0.00%. PACS Group's return on equity of 17.60% beat The Ensign Group's return on equity.
The Ensign Group has higher revenue and earnings than PACS Group.
In the previous week, PACS Group had 22 more articles in the media than The Ensign Group. MarketBeat recorded 30 mentions for PACS Group and 8 mentions for The Ensign Group. PACS Group's average media sentiment score of 1.10 beat The Ensign Group's score of 0.22 indicating that The Ensign Group is being referred to more favorably in the news media.
The Ensign Group received 341 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 66.10% of users gave The Ensign Group an outperform vote.
PACS Group presently has a consensus target price of $31.00, suggesting a potential upside of 9.89%. The Ensign Group has a consensus target price of $124.60, suggesting a potential upside of 4.02%. Given The Ensign Group's stronger consensus rating and higher probable upside, equities analysts clearly believe PACS Group is more favorable than The Ensign Group.
96.1% of The Ensign Group shares are held by institutional investors. 3.9% of The Ensign Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
The Ensign Group beats PACS Group on 8 of the 13 factors compared between the two stocks.
Get The Ensign Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for ENSG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ENSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Ensign Group Competitors List
Related Companies and Tools
